We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1,640.50 | 1,640.00 | 1,640.50 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.71 | 67.54B |
Date | Subject | Author | Discuss |
---|---|---|---|
02/3/2015 09:25 | that's true. can't see that happening though... | unastubbs | |
02/3/2015 09:20 | All about timing now = if they make the return before 5 April, then the new rules won't apply. | tradermichael | |
02/3/2015 08:28 | "Companies use special purpose share schemes to offer shareholders the choice to receive either a dividend or to receive a similar amount through an issue of new shares that are subsequently purchased by the company or sold to a pre-arranged third party. This measure will align the tax consequences of that choice to ensure that all shareholders are taxed as if they had received a dividend." In the light of that what are the benefits of a b share scheme over a special dividend? In the RNS this morning it is confirmed to be a b scheme. | unastubbs | |
02/3/2015 08:00 | atlantic - true - but does the market pay attention to morningstar? thought moody's or fitch were the preferred agencies. seems it is a b share scheme. i thought i read somewhere that the last autumn statement negated the tax benefits of such a scheme. completely unsure of that - b scheme it is. | unastubbs | |
02/3/2015 07:41 | Deal completed. | philo124 | |
01/3/2015 09:45 | Philanderer we are in a state considerable economic uncertainty with the risk of nations/ Banks/ Companies at risk of going bust. An A plus rating is worth a lot if true and could well drive share price up on this metric alone. | atlantic57 | |
01/3/2015 09:31 | GlaxoSmithKline plc (NYSE:GSK) has been given an “A+” credit rating by analysts at Morningstar. The investmentresearch firm’s “A+” rating suggests that the company isa low default risk. They also gave their stock a three star rating | philanderer | |
27/2/2015 12:59 | 26th feb Sanford C Bernstein market perform tp 1539p reiterates GlaxoSmithKline plc (NYSE:GSK) was upgraded by stock analysts at TheStreet from a “hold” rating to a “buy” rating in a report issued on Thursday. | philanderer | |
27/2/2015 09:45 | I didn't think they had confirmed it would be via 'B' shares yet? Will probably announce dates next week once deal is confirmed | mr woodentop | |
27/2/2015 09:36 | Do we know the "ex dividend" date for the issue of B shares yet? | jadeticl3 | |
26/2/2015 16:43 | Madengland, I've noticed that that has happened for the last three or four days now, strong surge up in last hour or so - almost as though all share sales are being hovered-up... | woodhawk | |
26/2/2015 16:19 | Like Standard Life...maybe trying to rush it through before tax year-end...then consolidation as with former? | cyberian | |
26/2/2015 15:42 | Nice tick up again near close | madengland | |
26/2/2015 15:07 | LONDON--Pharmaceutic The three-part transaction with Novartis includes Glaxo's acquisition of Novartis's vaccines business, the creation of a consumer healthcare joint venture and the divestment to Novartis of Glaxo. That's sooner than expected, so very good news | tradermichael | |
26/2/2015 10:01 | Nope because the spreadbet would reflect the payout and the price would drop but you would get cash equivalent paid in. | toffeeman | |
26/2/2015 09:46 | Trader Michael Well if it is that simple presumably you could simply open a spreadbet just before the special dividend is paid. Is it really that simple! | atlantic57 | |
26/2/2015 09:39 | I appreciate that was an update on information that has been in the public domain for months - I wasn't expecting a concurrent 83p rise int he SP!! Thanks anyway. | woodhawk | |
26/2/2015 09:28 | Woodhawk GSK are traded on the US exchange as ADRs the news came out yesterday after the UK market had closed but while the US was open and so if the news was significant it would have moved the ADRs and thence the UK shares this am. HTH | toffeeman | |
26/2/2015 07:28 | The price has climbed steadily as the news has developed, and it will likely drop 83p when the Special payout comes about. | tradermichael | |
25/2/2015 21:16 | Toffeeman, can you explain what you mean please? | woodhawk | |
25/2/2015 21:06 | Yep - if it wasn't then the ADRs would have moved more than they have | toffeeman | |
25/2/2015 20:52 | I assume it's built into the current sp, but maybe not. We will soon see | madengland | |
25/2/2015 17:39 | More news re Novartis deal late today. Wonder if there will be a surge in share price when more people realise that there is likely to be an imminent large special divi in the form of the B shares? | woodhawk | |
25/2/2015 13:31 | GlaxoSmithKline Consumer Healthcare Announces The Return of alli® to Retail Stores | tradermichael |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions